首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3219篇
  免费   66篇
管理学   484篇
民族学   29篇
人口学   244篇
丛书文集   18篇
理论方法论   332篇
现状及发展   1篇
综合类   28篇
社会学   1667篇
统计学   482篇
  2023年   24篇
  2022年   13篇
  2021年   30篇
  2020年   65篇
  2019年   91篇
  2018年   98篇
  2017年   112篇
  2016年   90篇
  2015年   83篇
  2014年   98篇
  2013年   568篇
  2012年   123篇
  2011年   122篇
  2010年   94篇
  2009年   84篇
  2008年   121篇
  2007年   94篇
  2006年   93篇
  2005年   87篇
  2004年   79篇
  2003年   73篇
  2002年   84篇
  2001年   72篇
  2000年   61篇
  1999年   62篇
  1998年   50篇
  1997年   43篇
  1996年   36篇
  1995年   46篇
  1994年   43篇
  1993年   21篇
  1992年   23篇
  1991年   35篇
  1990年   34篇
  1989年   21篇
  1988年   34篇
  1987年   27篇
  1986年   25篇
  1985年   33篇
  1984年   29篇
  1983年   29篇
  1982年   26篇
  1981年   35篇
  1980年   28篇
  1979年   24篇
  1978年   20篇
  1977年   10篇
  1976年   19篇
  1975年   18篇
  1974年   13篇
排序方式: 共有3285条查询结果,搜索用时 0 毫秒
1.
ABSTRACT

The cost and time of pharmaceutical drug development continue to grow at rates that many say are unsustainable. These trends have enormous impact on what treatments get to patients, when they get them and how they are used. The statistical framework for supporting decisions in regulated clinical development of new medicines has followed a traditional path of frequentist methodology. Trials using hypothesis tests of “no treatment effect” are done routinely, and the p-value < 0.05 is often the determinant of what constitutes a “successful” trial. Many drugs fail in clinical development, adding to the cost of new medicines, and some evidence points blame at the deficiencies of the frequentist paradigm. An unknown number effective medicines may have been abandoned because trials were declared “unsuccessful” due to a p-value exceeding 0.05. Recently, the Bayesian paradigm has shown utility in the clinical drug development process for its probability-based inference. We argue for a Bayesian approach that employs data from other trials as a “prior” for Phase 3 trials so that synthesized evidence across trials can be utilized to compute probability statements that are valuable for understanding the magnitude of treatment effect. Such a Bayesian paradigm provides a promising framework for improving statistical inference and regulatory decision making.  相似文献   
2.
Multi-valued strategy-proof social choice rules   总被引:10,自引:4,他引:6  
In this paper we introduce a new definition of strategy-proofness for multi-valued social choice correspondences. We prove two Gibbard-Satterthwaite type results for strategy-proof social choice correspondences. These results show that allowing multiple outcomes as social choices will not necessarily lead to an escape from the Gibbard-Satterthwaite impossibility theorem. Received: 24 January 2001/Accepted: 19 March 2001  相似文献   
3.
Service-learning programs are not free from challenges brought about by lack of financial support, lack of widespread commitment from professors, community agencies, and recipients of service, and lack of knowledge and insight in students directly involved in such programs. While service-learning initiatives and programs serve positive functions for organizations and individuals, rhetorical accolades for service learning can distort or omit the realities of program implementation and sustained delivery. This paper specifically explores the following challenges connected to service-learning programs: (1) pedagogical difficulties; (2) student limitations; (3) time constraints; and (4) community cooperation.  相似文献   
4.
5.
6.
7.
8.
Laud et al. (1993) describe a method for random variate generation from D-distributions. In this paper an alternative method using substitution sampling is given. An algorithm for the random variate generation from SD-distributions is also given.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号